Abstract

BackgroundHDL cholesterol (HDL-C) is an established marker of cardiovascular risk with significant genetic determination. However, HDL particles are not homogenous, and refined HDL phenotyping may improve insight into regulation of HDL metabolism. We therefore assessed HDL particles by NMR spectroscopy and conducted a large-scale candidate gene association analysis.Methodology/Principal FindingsWe measured plasma HDL-C and determined mean HDL particle size and particle number by NMR spectroscopy in 2024 individuals from 512 British Caucasian families. Genotypes were 49,094 SNPs in >2,100 cardiometabolic candidate genes/loci as represented on the HumanCVD BeadChip version 2. False discovery rates (FDR) were calculated to account for multiple testing. Analyses on classical HDL-C revealed significant associations (FDR<0.05) only for CETP (cholesteryl ester transfer protein; lead SNP rs3764261: p = 5.6*10−15) and SGCD (sarcoglycan delta; rs6877118: p = 8.6*10−6). In contrast, analysis with HDL mean particle size yielded additional associations in LIPC (hepatic lipase; rs261332: p = 6.1*10−9), PLTP (phospholipid transfer protein, rs4810479: p = 1.7*10−8) and FBLN5 (fibulin-5; rs2246416: p = 6.2*10−6). The associations of SGCD and Fibulin-5 with HDL particle size could not be replicated in PROCARDIS (n = 3,078) and/or the Women's Genome Health Study (n = 23,170).ConclusionsWe show that refined HDL phenotyping by NMR spectroscopy can detect known genes of HDL metabolism better than analyses on HDL-C.

Highlights

  • HDL cholesterol (HDL-C) is an established marker of cardiovascular risk

  • We show that refined HDL phenotyping by NMR spectroscopy can detect known genes of HDL metabolism better than analyses on HDL-C

  • Subjects Genotypes, plasma HDL-C and NMR HDL particle traits were available on 2024 GRAPHIC subjects

Read more

Summary

Introduction

HDL cholesterol (HDL-C) is an established marker of cardiovascular risk. It reflects reverse cholesterol transport (RCT) and higher plasma HDL-C is associated with lower cardiovascular risk. The cholesterol content of HDL particles is mainly a historically founded and analytically feasible surrogate of RCT and is it not clear whether HDL-C is the best RCT-related cardiovascular risk marker [1,2,3,4,5]. Most studies suggest that large HDL particles are associated with a favourable outcome, while small HDL particles may even be positively correlated with CV risk [1,5,6]. HDL cholesterol (HDL-C) is an established marker of cardiovascular risk with significant genetic determination. We assessed HDL particles by NMR spectroscopy and conducted a large-scale candidate gene association analysis

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call